Behavioral and Clinical Characteristics of Persons with Diagnosed HIV Infection—Medical Monitoring Project, United States 2021 Cycle (June 2021–May 2022): Figures
Figure 1. Participating Medical Monitoring Project Sites, Including 16 States and 6 Separately Funded Jurisdictions—United States, 2021
Figure 2a. Distribution of Gender Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Note. Transgender persons defined as those who self-identified as transgender or who reported a gender identity different from sex assigned at birth.
Figure 2b. Distribution of Age Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Figure 2c. Distribution of Sexual Orientation Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Figure 2d. Distribution of Race/Ethnicity Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Note. Data for Native Hawaiian and other Pacific Islander persons are not included because the estimate is unstable and therefore suppressed. Hispanic/Latino persons could identify as any race and are grouped separately.
Figure 3a. Prevalence of Socioeconomic Factors and Incarceration Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
* Homelessness is defined as living on the street, in a shelter, in a single-room-occupancy hotel, or in a car at any time during the past 12 months.
† Hunger or food insecurity is defined as going without food due to lack of money during the past 12 months.
‡ Unemployment or inability to work includes those who were unemployed or unable to work at the time of the interview; employed included employed for wages, self-employed, or homemaker.
** Household poverty level is based on HHS poverty guidelines. The 2020 guidelines were used for persons interviewed in 2021 and the 2021 guidelines were used for persons interviewed in 2022. More information regarding HHS poverty guidelines can be found at: https://aspe.hhs.gov/frequently-asked-questions-related-poverty-guidelines-and-poverty.
†† Incarcerated >24 hours at any point during the past 12 months.
Figure 3b. Prevalence of SSI and SSDI Benefits Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Abbreviations. SSI=Supplemental Security Income; SSDI=Social Security Disability Insurance.
Figure 3c. Prevalence of Health Insurance of Coverage for Care or Medications Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
Abbreviations. RWHAP=Ryan White HIV/AIDS Program.
Note. Health care insurance/coverage types not mutually exclusive; people could report >1 type of coverage.
* Includes people who only have health care through the Ryan White HIV/AIDS Program.
Figure 4. Percentage of Adults with Diagnosed HIV Who Were Virally Suppressed During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
* Viral load <200 copies/mL or undetectable based on most recent test in the past 12 months.
† Sustained viral suppression defined as having all viral load tests in the past 12 months <200 copies/mL or undetectable.
Figure 5. Receipt of HIV Care and Antiretroviral Therapy Prescription During the 12 Months Before Interview Among Adults with Diagnosed HIV—Medical Monitoring Project, United States, 2021
* Outpatient HIV care was defined as any documentation of the following: encounter with an HIV care provider, viral load test results, CD4 test result, HIV resistance test or tropism assay, ART prescription, PCP prophylaxis, or MAC prophylaxis.
† Had ≥2 elements of outpatient HIV care at least 90 days apart during the 12 months prior to interview.
Figure 6. Percentage of Sexually Active Adults with Diagnosed HIV Who Tested for Gonorrhea, Chlamydia, or Syphilis During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 7. Percentage of Adults with Diagnosed HIV Who Had At Least One Visit to the Emergency Room Or At Least One Hospital Admission During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 8. Reasons for Missing Last Antiretroviral Therapy Dose Among Adults with Diagnosed HIV Who Have Ever Missed a Dose*—Medical Monitoring Project, United States, 2021
* Participant may report more than one reason for last missed dose.
Figure 9a. Percentage of Adults with Diagnosed HIV Who Experienced Symptoms of Major or Other Depression* During the Two Weeks Before Interview—Medical Monitoring Project, United States, 2021
* Responses to the items on the PHQ-8 were used to define “major depression” and “other depression” according to criteria from the DSM-IV. “Major depression” was defined as having at least 5 symptoms of depression; “other depression” was defined as having 2–4 symptoms of depression. The PHQ-8 classification “other depression” comprises the DSM-IV categories of dysthymia and depressive disorder, not otherwise specified, which includes minor or subthreshold depression.
Figure 9b. Percentage of Adults with Diagnosed HIV Who Experienced Symptoms of Generalized Anxiety Disorder* During the Two Weeks Before Interview—Medical Monitoring Project, United States, 2021
* Responses to the GAD-7 were used to define “mild anxiety,” “moderate anxiety,” and “severe anxiety,” according to criteria from the DSM-IV. “Severe anxiety” was defined as having a score of ≥15; “moderate anxiety” was defined as having a score of 10–14; and “mild anxiety” was defined as having a score of 5–9.
Figure 10a. Percentage of Adults with Diagnosed HIV Who Smoked Cigarettes During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 10b. Percentage of Adults with Diagnosed HIV Who Drank Alcohol During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
* Persons who drank ≥ 5 alcoholic beverages in a single sitting (≥ 4 for women) during the 30 days before interview.
Figure 10c. Percentage of Adults with Diagnosed HIV Who Used Drugs for Nonmedical Purposes During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
* Includes all drugs that were not injected (i.e., administered by any route other than injection), including legal drugs that were not used for medical purposes, and vaping marijuana.
Figure 11. Percentage of Cisgender Female Adults with Diagnosed HIV Who Had a Papanicolaou Test During the Three Years Before Interview Or Became Pregnant Since Receiving an HIV Diagnosis—Medical Monitoring Project, United States, 2021
Figure 12. Percentage of Sexually Active Adults with Diagnosed HIV Who Engaged in Sex Without Using an HIV Prevention Strategy* During the 12 Months Before Interview, by Sexual Behavior/Orientation—Medical Monitoring Project, United States, 2021
Abbreviations. MSM=cisgender men who have sex with cisgender men; MSW=cisgender men who have sex only with cisgender women; WSM=cisgender women who have sex with cisgender men.
* Vaginal or anal sex with at least 1 HIV-negative or unknown status partner while not having sustained viral suppression (all viral load measurements in the past 12 months undetectable or <200 copies/mL), when a condom was not used, and the partner was not known to be taking preexposure prophylaxis (PrEP).
Figure 13. Prevention Strategies Used During the 12 Months Before Interview Among Sexually Active Persons with Diagnosed HIV, Including Cisgender Men Who Have Sex with Cisgender Men, Cisgender Men Who Have Sex with Only Cisgender Women, and Cisgender Women Who Have Sex with Cisgender Men—Medical Monitoring Project, United States, 2021
Abbreviations. MSM=cisgender men who have sex with cisgender men; MSW=cisgender men who have sex only with cisgender women; WSM=cisgender women who have sex with cisgender men.
* Estimate is unreliable and therefore suppressed due to having a coefficient of variation ≥0.30 or a denominator sample size <30.
Figure 14a. Percentage of Adults with Diagnosed HIV Who Received, or Who Needed But Did Not Receive, Ancillary Services Related to HIV Support During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Abbreviations. ADAP=AIDS Drug Assistance Program; ART=Antiretroviral Therapy.
Figure 14b. Percentage of Adults with Diagnosed HIV Who Received, or Who Needed But Did Not Receive, Ancillary Services Related to Non-HIV Medical Services During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 14c. Percentage of Adults with Diagnosed HIV Who Received, or Who Needed But Did Not Receive, Ancillary Services Related to Subsistence Services During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Abbreviations. SNAP=Supplemental Nutrition Assistance Program; WIC=Special Supplemental Nutrition Program for Women, Infants, and Children.
* Includes services such as soup kitchens, food pantries, church dinners, or food delivery services.
Figure 15. Percentage of Adults with Diagnosed HIV Who Experienced Physical Violence by an Intimate Partner or Forced Sex During Their Lifetime or the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 16. Receipt of HIV or Sexually Transmitted Disease Prevention Services During the 12 Months Before Interview—Medical Monitoring Project, United States, 2021
Figure 17. National HIV/AIDS Strategy Indicator: Good or Better Self-Rated Health* Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2018–2021
* “Good or better self-rated health” defined as rating one’s health as good, very good, or excellent (as opposed to poor or fair) at the time of interview.
Figure 18. National HIV/AIDS Strategy Indicator: Unmet Needs for Mental Health Services* During the 12 Months Before Interview Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2015–2021
* “Unmet need for mental health services from a mental health professional” defined as needing, but not receiving, services from a mental health professional among those who indicated needing mental health services (i.e., receiving or needing but not receiving) during the past 12 months.
Figure 19. National HIV/AIDS Strategy Indicator: Unstable Housing or Homelessness* During the 12 Months Before Interview Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2018–2021
* “Unstable housing or homelessness” defined as experiencing unstable housing (i.e., moving in with others due to financial issues, moving 2 or more times, or being evicted at any time) or homelessness (living on the street, in a shelter, in a single-room–occupancy hotel, or in a car at any time) during the past 12 months.
Figure 20. National HIV/AIDS Strategy Indicator: Unemployment* Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2015–2021
* Unemployed persons included those who reported being unemployed at the time of the interview.
Figure 21. National HIV/AIDS Strategy Indicator: Hunger/Food Insecurity* During the 12 Months Before Interview Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2015–2021
* “Hunger/food insecurity” defined as going without food due to lack of money during the past 12 months.
Figure 22. National HIV/AIDS Strategy Indicator: Median HIV Stigma Scores* During the 12 Months Before Interview Among Adults with Diagnosed HIV, By Cycle Year—Medical Monitoring Project, United States, 2018–2021
*“Median HIV stigma score” defined as the weighted median score on a 10-item scale ranging from 0 (no stigma) to 100 (high stigma) that measures 4 dimensions of HIV stigma: personalized stigma during the past 12 months, current disclosure concerns, current negative self-image, and current perceived public attitudes about people living with HIV, measured among persons aged ≥18 years with diagnosed HIV infection living in the United States and Puerto Rico.